Copyright Reports & Markets. All rights reserved.

Global Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prenatal and Newborn Genetic Testing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Array-Comparative Genetic Hybridization (aCGH)
    • 1.4.3 Fluorescence In-Situ Hybridization (FISH)
    • 1.4.4 Polymerase Chain Reaction (PCR)
  • 1.5 Market by Application
    • 1.5.1 Global Prenatal and Newborn Genetic Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Diagnostic Organization
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Prenatal and Newborn Genetic Testing Market Perspective (2015-2026)
  • 2.2 Global Prenatal and Newborn Genetic Testing Growth Trends by Regions
    • 2.2.1 Prenatal and Newborn Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prenatal and Newborn Genetic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prenatal and Newborn Genetic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prenatal and Newborn Genetic Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prenatal and Newborn Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prenatal and Newborn Genetic Testing Players by Market Size
    • 3.1.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio
    • 3.2.1 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prenatal and Newborn Genetic Testing Revenue in 2019
  • 3.3 Prenatal and Newborn Genetic Testing Key Players Head office and Area Served
  • 3.4 Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
  • 3.5 Date of Enter into Prenatal and Newborn Genetic Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
  • 5.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 6.2 Prenatal and Newborn Genetic Testing Key Players in North America (2019-2020)
  • 6.3 North America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 6.4 North America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 7.2 Prenatal and Newborn Genetic Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 7.4 Europe Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 8.2 Prenatal and Newborn Genetic Testing Key Players in China (2019-2020)
  • 8.3 China Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 8.4 China Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 9.2 Prenatal and Newborn Genetic Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 9.4 Japan Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 10.2 Prenatal and Newborn Genetic Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 11.2 Prenatal and Newborn Genetic Testing Key Players in India (2019-2020)
  • 11.3 India Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 11.4 India Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prenatal and Newborn Genetic Testing Market Size (2015-2020)
  • 12.2 Prenatal and Newborn Genetic Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Roche Diagnostic
    • 13.1.1 Roche Diagnostic Company Details
    • 13.1.2 Roche Diagnostic Business Overview
    • 13.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Introduction
    • 13.1.4 Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020))
    • 13.1.5 Roche Diagnostic Recent Development
  • 13.2 Elitech Group
    • 13.2.1 Elitech Group Company Details
    • 13.2.2 Elitech Group Business Overview
    • 13.2.3 Elitech Group Prenatal and Newborn Genetic Testing Introduction
    • 13.2.4 Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.2.5 Elitech Group Recent Development
  • 13.3 Myriad Genetics
    • 13.3.1 Myriad Genetics Company Details
    • 13.3.2 Myriad Genetics Business Overview
    • 13.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Introduction
    • 13.3.4 Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.3.5 Myriad Genetics Recent Development
  • 13.4 Biocartis
    • 13.4.1 Biocartis Company Details
    • 13.4.2 Biocartis Business Overview
    • 13.4.3 Biocartis Prenatal and Newborn Genetic Testing Introduction
    • 13.4.4 Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.4.5 Biocartis Recent Development
  • 13.5 IntegraGen
    • 13.5.1 IntegraGen Company Details
    • 13.5.2 IntegraGen Business Overview
    • 13.5.3 IntegraGen Prenatal and Newborn Genetic Testing Introduction
    • 13.5.4 IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.5.5 IntegraGen Recent Development
  • 13.6 Perkin Elmer
    • 13.6.1 Perkin Elmer Company Details
    • 13.6.2 Perkin Elmer Business Overview
    • 13.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Introduction
    • 13.6.4 Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.6.5 Perkin Elmer Recent Development
  • 13.7 WaferGen Biosystem
    • 13.7.1 WaferGen Biosystem Company Details
    • 13.7.2 WaferGen Biosystem Business Overview
    • 13.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Introduction
    • 13.7.4 WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.7.5 WaferGen Biosystem Recent Development
  • 13.8 Interpace Diagnostics
    • 13.8.1 Interpace Diagnostics Company Details
    • 13.8.2 Interpace Diagnostics Business Overview
    • 13.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Introduction
    • 13.8.4 Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.8.5 Interpace Diagnostics Recent Development
  • 13.9 Quest Diagnostic
    • 13.9.1 Quest Diagnostic Company Details
    • 13.9.2 Quest Diagnostic Business Overview
    • 13.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Introduction
    • 13.9.4 Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.9.5 Quest Diagnostic Recent Development
  • 13.10 Bio-Rad
    • 13.10.1 Bio-Rad Company Details
    • 13.10.2 Bio-Rad Business Overview
    • 13.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Introduction
    • 13.10.4 Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 13.10.5 Bio-Rad Recent Development
  • 13.11 AutoGenomics
    • 10.11.1 AutoGenomics Company Details
    • 10.11.2 AutoGenomics Business Overview
    • 10.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Introduction
    • 10.11.4 AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.11.5 AutoGenomics Recent Development
  • 13.12 Abbott
    • 10.12.1 Abbott Company Details
    • 10.12.2 Abbott Business Overview
    • 10.12.3 Abbott Prenatal and Newborn Genetic Testing Introduction
    • 10.12.4 Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.12.5 Abbott Recent Development
  • 13.13 Cepheid
    • 10.13.1 Cepheid Company Details
    • 10.13.2 Cepheid Business Overview
    • 10.13.3 Cepheid Prenatal and Newborn Genetic Testing Introduction
    • 10.13.4 Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.13.5 Cepheid Recent Development
  • 13.14 EKF Diagnostics
    • 10.14.1 EKF Diagnostics Company Details
    • 10.14.2 EKF Diagnostics Business Overview
    • 10.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Introduction
    • 10.14.4 EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.14.5 EKF Diagnostics Recent Development
  • 13.15 Natera
    • 10.15.1 Natera Company Details
    • 10.15.2 Natera Business Overview
    • 10.15.3 Natera Prenatal and Newborn Genetic Testing Introduction
    • 10.15.4 Natera Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.15.5 Natera Recent Development
  • 13.16 Agilent Technologies
    • 10.16.1 Agilent Technologies Company Details
    • 10.16.2 Agilent Technologies Business Overview
    • 10.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Introduction
    • 10.16.4 Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.16.5 Agilent Technologies Recent Development
  • 13.17 Illumina
    • 10.17.1 Illumina Company Details
    • 10.17.2 Illumina Business Overview
    • 10.17.3 Illumina Prenatal and Newborn Genetic Testing Introduction
    • 10.17.4 Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.17.5 Illumina Recent Development
  • 13.18 Ariosa Diagnostics
    • 10.18.1 Ariosa Diagnostics Company Details
    • 10.18.2 Ariosa Diagnostics Business Overview
    • 10.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Introduction
    • 10.18.4 Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.18.5 Ariosa Diagnostics Recent Development
  • 13.19 Sequenom
    • 10.19.1 Sequenom Company Details
    • 10.19.2 Sequenom Business Overview
    • 10.19.3 Sequenom Prenatal and Newborn Genetic Testing Introduction
    • 10.19.4 Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
    • 10.19.5 Sequenom Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Prenatal and Newborn Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prenatal and Newborn Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Roche Diagnostic
    Elitech Group
    Myriad Genetics
    Biocartis
    IntegraGen
    Perkin Elmer
    WaferGen Biosystem
    Interpace Diagnostics
    Quest Diagnostic
    Bio-Rad
    AutoGenomics
    Abbott
    Cepheid
    EKF Diagnostics
    Natera
    Agilent Technologies
    Illumina
    Ariosa Diagnostics
    Sequenom

    Market segment by Type, the product can be split into
    Array-Comparative Genetic Hybridization (aCGH)
    Fluorescence In-Situ Hybridization (FISH)
    Polymerase Chain Reaction (PCR)
    Market segment by Application, split into
    Hospitals
    Diagnostic Organization
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now